GRIDAI TECHNOLOGIES CORP (GRDX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GRDX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 781.8% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
GRDX — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-07-07
Unregistered Sales of Equity Securities. The disclosure under
Why it matters: Filing the 10-K is crucial for compliance and transparency. Delays could harm credibility.
Worry ifThe company successfully files its 10-K report by the deadline.
Less concerning ifThe company fails to file the 10-K by June 22, 2026.
Why it matters: Getting financing is key for the company's work and growth. It shows financial health.
Supportive ifThe company finishes more financing rounds or gets new loans.
Worry ifThe company does not get the needed financing. This causes operational problems.
Why it matters: The company's plan to regain Nasdaq compliance is critical for its listing status. If Nasdaq accepts the plan, it may extend the compliance deadline.
Supportive ifNasdaq accepts the company's compliance plan and grants an extension of up to 180 days.
Worry ifNasdaq does not accept the compliance plan. This may lead to delisting.
Why it matters: The company is at risk of being delisted. Compliance is crucial for its future.
Worry ifA notice from Nasdaq confirming that compliance with listing rules has been achieved.
Less concerning ifNasdaq might send more warnings about not following rules. They could also decide to delist.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$487 on $10,000 · ±4.9% | How much price usually moves either way. |
| Bad day | $1,295 loss on $10,000 · 12.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,439 loss on $10,000 · 64.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Financing is critical to support operations and reduce losses. It impacts future growth.
Supportive ifThe company announces a new financing round that raises at least $2 million.
Worry ifThe company does not get more financing. This makes cash flow problems worse.
Why it matters: Getting funding is key for operations. It shows investor trust and can help the company’s finances.
Supportive ifThe company shares news of successful funding rounds that total over $2 million.
Worry ifThe company fails to secure any new financing in Q3 2026.
Why it matters: Securing more financing is vital for ongoing operations and growth. It shows financial health.
Supportive ifThe company shares news about a new financing round or partnership.
Worry ifNo announcements of new financing or partnerships by end of Q3 2026.
Why it matters: The company lost a lot of money. Fixing this is key for stability.
Supportive ifOperating losses decrease to less than -$2 million in the next quarter.
Worry ifOperating losses remain at or worsen beyond -$3 million.
Why it matters: New financing is crucial for GridAI to support operations and growth plans.
Supportive ifGridAI has a new financing deal over $2 million before the next earnings report.
Worry ifNo new financing is announced, raising concerns about cash flow.
Why it matters: Ongoing losses may show bigger problems with costs and operations. Investors worry about finances.
Worry ifOperating losses grow past negative $13.1 million from Q2.
Less concerning ifOperating losses go down or stay the same compared to last quarter.
Why it matters: The outcome affects GridAI's listing status on Nasdaq. A delisting could hurt investor confidence.
Worry ifNasdaq accepts the compliance plan submitted by GridAI by June 22, 2026.
Less concerning ifNasdaq rejects the compliance plan or does not grant an extension by October 12, 2026.
Why it matters: Submitting a compliance plan is crucial for maintaining the Nasdaq listing. If accepted, it allows more time to regain compliance.
Supportive ifThe company submits a compliance plan to Nasdaq by the June 22 deadline.
Worry ifThe company fails to submit a compliance plan by June 22.